DVA · DaVita Inc
United States · RS rating 78 · As of 2026-11-03
| Price | 182.17 USD |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 63 / 59 / 86 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 45 / 57 / 38 |
| Industry group (rank) | Medical-Outpnt/Hm Care (19) |
| EPS growth Q/Q | +61.3% |
| Sales growth Q/Q | +5.8% |
| Distance from 52-week high | +24.4% |
| Market cap (USD) | $10.2B |